GlassScriptPhysician profile
Dimitria Papadopoulos
NPI 1689640245
$19,979.79
in general payments reported to CMS, 2019-2025
47 companies · $3,037 in 2025
The $3,037 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,418 · 2020: $2,746 · 2021: $2,800 · 2022: $1,869 · 2023: $2,475 · 2024: $2,633 · 2025: $3,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,828 · Education: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,827.61 |
| Education | $317.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $1,470.65 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
| Abbvie INC. | $1,283.41 | 2019-2025 | |
| Lilly USA, LLC | $1,150.05 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Amgen INC. | $1,130.47 | 2020-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $1,113.96 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Novartis Pharmaceuticals Corporation | $1,028.00 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,022.23 | 2019-2025 | Cabtreo, Siliq, Jublia |
| Journey Medical Corporation | $996.90 | 2019-2025 | |
| Galderma Laboratories, L.P. | $991.51 | 2019-2025 | Aklief, Nemluvio, Epsolay |
| Leo Pharma INC. | $934.52 | 2019-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $854.73 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $674.92 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $633.03 | 2019-2025 | Dupixent |
| Almirall LLC | $632.53 | 2019-2025 | Klisyri |
| Pfizer INC. | $589.78 | 2019-2025 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dimitria Papadopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.